BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35958281)

  • 1. Pan-Cancer Analysis of Voltage-Dependent Anion Channel (VDAC1) as a Cancer Therapeutic Target or Diagnostic Biomarker.
    Wang Z; Cheng Y; Song Z; Zhao R
    Dis Markers; 2022; 2022():5946110. PubMed ID: 35958281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
    Guo B; Wang Y; Liu W; Zhang S
    Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
    Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
    World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implication of voltage-dependent anion channel 1 in uterine cervical cancer and its action on cervical cancer cells.
    Wu CH; Lin YW; Wu TF; Ko JL; Wang PH
    Oncotarget; 2016 Jan; 7(4):4210-25. PubMed ID: 26716410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancancer Analysis of the Oncogenic and Prognostic Role of
    Liu Q; Xie R; Li Y
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-cancer analysis of G6PD carcinogenesis in human tumors.
    Liu B; Fu X; Du Y; Feng Z; Chen R; Liu X; Yu F; Zhou G; Ba Y
    Carcinogenesis; 2023 Aug; 44(6):525-534. PubMed ID: 37335542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts.
    Zeng Z; Gao Y; Li J; Zhang G; Sun S; Wu Q; Gong Y; Xie C
    Comput Struct Biotechnol J; 2022; 20():496-507. PubMed ID: 35070171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling of mitochondrial voltage-dependent anion channel-1 associated genes predicts recurrence-free survival in human carcinomas.
    Ko JH; Gu W; Lim I; Zhou T; Bang H
    PLoS One; 2014; 9(10):e110094. PubMed ID: 25333947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis.
    Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K
    Front Immunol; 2022; 13():903461. PubMed ID: 35663977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Pan-Cancer Analysis of the Tumorigenic Effect of Leucine-Zipper-Like Transcription Regulator (LZTR1) in Human Cancer.
    Zhou B; Ying X; Chen Y; Cai X
    Oxid Med Cell Longev; 2022; 2022():2663748. PubMed ID: 36304963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analysis of prognostic value and immunological role of MeCP2 in pan-cancer.
    Wang Y; Zhang Y; Wang F; Li T; Song X; Shi H; Du J; Zhang H; Jing H; Han J; Tong D; Zhang J
    Sci Rep; 2022 Nov; 12(1):18518. PubMed ID: 36323715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The panoramic picture of pepsinogen gene family with pan-cancer.
    Shen S; Li H; Liu J; Sun L; Yuan Y
    Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors.
    Ding Q; Li R; Wang Q; Yu L; Zi F
    Front Oncol; 2023; 13():1049147. PubMed ID: 38053661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
    Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
    Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. System biology analysis reveals the role of voltage-dependent anion channel in mitochondrial dysfunction during non-alcoholic fatty liver disease progression into hepatocellular carcinoma.
    Zhu Y; Zhang C; Xu F; Zhao M; Bergquist J; Yang C; Liu X; Tan Y; Wang X; Li S; Jiang W; Ong Q; Lu L; Mi J; Tian G
    Cancer Sci; 2020 Nov; 111(11):4288-4302. PubMed ID: 32945042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of TMEM59L and its genomic and immunological characteristics in cancer.
    Shi C; Zhang L; Chen D; Wei H; Qi W; Zhang P; Guo H; Sun L
    Front Immunol; 2022; 13():1054157. PubMed ID: 36618425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer.
    Li L; Feng Q; Wang X
    Comput Struct Biotechnol J; 2020; 18():668-675. PubMed ID: 32257050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker.
    Dong Q; Yan L; Xu Q; Hu X; Yang Y; Zhu R; Xu Q; Yang Y; Wang B
    Front Genet; 2022; 13():944970. PubMed ID: 36118871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.